Stock Comparison
JAZZ vs VRTX
Jazz Pharmaceuticals PLC and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$15.96B
$123.94B
P/E (TTM)
16.8
28.5
Forward P/E
10.3
25.7
Price/Sales
3.5
9.9
Price/Book
3.3
6.1
EV/EBITDA
11.3
23.2
Dividend Yield
—
—
Profitability
Net Margin
0.66%
35.40%
Operating Margin
11.13%
38.97%
Return on Equity
22.10%
23.50%
Return on Assets
6.86%
11.90%
Growth (YoY)
Revenue Growth
15.50%
12.50%
Earnings Growth
3.20%
8.00%
Price & Risk
Beta
0.4
0.3
52-Week High
$261.62
$529.65
52-Week Low
$116.67
$376.62
Analyst Target
$280.95
$559.28
Compare JAZZ and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.